National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-GP-3 monoclonal antibody
A humanized, immunoglobulin G1 monoclonal antibody with potential antitumor activity. MORab-003 specifically targets at glycoprotein 3 (GP-3), a cell surface antigen that is overexpressed on many epithelial-derived cancer cells. Upon binding to the GP-3 antigen, MORab-003 triggers a host immune response against GP-3 expressing cells resulting in cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:MORAb-003



Previous:anti-EpCAM antibody fragment -Pseudomonas exotoxin fusion protein, anti-EpCAM antibody fragment-bouganin fusion protein, anti-EpCAM/anti-CD3 recombinant bispecific monoclonal antibody MT110, anti-ErbB3 receptor monoclonal antibody MM-121, anti-FLT-1 ribozyme
Next:anti-HER3 monoclonal antibody U3-1287, anti-HGF monoclonal antibody SCH900105, anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968, anti-human chorionic gonadotropin vaccine, anti-IGF-1 receptor human monoclonal antibody R1507

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov